Sex difference in clinical outcomes after percutaneous coronary intervention in Korean population

American Heart Journal

Volumn 167, Issue 5, 2014, Pages 743-752

  Park, Duk Woo ^a   Kim, Young Hak ^a   Yun, Sung Cheol ^a   Ahn, Jung Min ^a   Lee, Jong Young ^a   Kang, Soo Jin ^a   Lee, Seung Whan ^a   Lee, Cheol Whan ^a   Park, Seong Wook ^a   Park, Seung Jung ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; HEART INFARCTION; HUMAN; INCIDENCE; KOREA; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; SEX DIFFERENCE; STENT THROMBOSIS;

AGED; CLINICAL TRIALS AS TOPIC; CORONARY ARTERY DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; REPUBLIC OF KOREA; RISK FACTORS; SEX DISTRIBUTION; SEX FACTORS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84899422931     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2013.12.027     Document Type: Article

References (30)

1. J. Mehilli, A. Kastrati, and J. Dirschinger et al. Differences in prognostic factors and outcomes between women and men undergoing coronary artery stenting JAMA 284 2000 1799 1805
2. C. Milcent, B. Dormont, and I. Durand-Zaleski et al. Gender differences in hospital mortality and use of percutaneous coronary intervention in acute myocardial infarction: microsimulation analysis of the 1999 nationwide French hospitals database Circulation 115 2007 833 839
3. N. Akhter, S. Milford-Beland, and M.T. Roe et al. Gender differences among patients with acute coronary syndromes undergoing percutaneous coronary intervention in the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR) Am Heart J 157 2009 141 148
4. M.L. Anderson, E.D. Peterson, and J.M. Brennan et al. Short- and long-term outcomes of coronary stenting in women versus men: results from the National Cardiovascular Data Registry Centers for Medicare & Medicaid services cohort Circulation 126 2012 2190 2199
5. Draft guidance for industry and Food and Drug Administration staff: evaluation of sex differences in medical device clinical studies. Food and Drug Administration Web site. http://www.fda.gov/MedicalDevices/ DeviceRegulationandGuidance/GuidanceDocuments/ucm283453.htm. Updated December 19, 2011. Accessed April 6, 2012.
6. L.J. Shaw, R.E. Shaw, and C.N. Merz et al. Impact of ethnicity and gender differences on angiographic coronary artery disease prevalence and in-hospital mortality in the American College of Cardiology-National Cardiovascular Data Registry Circulation 117 2008 1787 1801
7. D.W. Park, Y.H. Kim, and S.C. Yun et al. Comparison of zotarolimus-eluting stents with sirolimus- and paclitaxel-eluting stents for coronary revascularization: the ZEST (comparison of the efficacy and safety of zotarolimus-eluting stent with sirolimus-eluting and paclitaxel-eluting stent for coronary lesions) randomized trial J Am Coll Cardiol 56 2010 1187 1195
8. C.W. Lee, D.W. Park, and S.H. Lee et al. Comparison of the efficacy and safety of zotarolimus-, sirolimus-, and paclitaxel-eluting stents in patients with ST-elevation myocardial infarction Am J Cardiol 104 2009 1370 1376
9. Y.H. Kim, S.W. Park, and S.W. Lee et al. Sirolimus-eluting stent versus paclitaxel-eluting stent for patients with long coronary artery disease Circulation 114 2006 2148 2153
10. D.W. Park, Y.H. Kim, and H.G. Song et al. Comparison of everolimus- and sirolimus-eluting stents in patients with long coronary artery lesions: a randomized LONG-DES-III (Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-III) Trial JACC Cardiovasc Interv 4 2011 1096 1103
11. J.M. Ahn, D.W. Park, and Y.H. Kim et al. Comparison of resolute zotarolimus-eluting stents and sirolimus-eluting stents in patients with de novo long coronary artery lesions: a randomized LONG-DES IV trial Circ Cardiovasc Interv 5 2012 633 640
12. W.J. Kim, S.W. Lee, and S.W. Park et al. Randomized comparison of everolimus-eluting stent versus sirolimus-eluting stent implantation for de novo coronary artery disease in patients with diabetes mellitus (ESSENCE-DIABETES): results from the ESSENCE-DIABETES trial Circulation 124 2011 886 892
13. S.W. Lee, S.W. Park, and Y.H. Kim et al. A randomized, double-blind, multicenter comparison study of triple antiplatelet therapy with dual antiplatelet therapy to reduce restenosis after drug-eluting stent implantation in long coronary lesions: results from the DECLARE-LONG II (Drug-Eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients with Long Coronary Lesions) trial J Am Coll Cardiol 57 2011 1264 1270
14. S.J. Park, D.W. Park, and Y.H. Kim et al. Duration of dual antiplatelet therapy after implantation of drug-eluting stents N Engl J Med 362 2010 1374 1382
15. D.W. Park, S.C. Yun, and S.W. Lee et al. Stent thrombosis, clinical events, and influence of prolonged clopidogrel use after placement of drug-eluting stent data from an observational cohort study of drug-eluting versus bare-metal stents JACC Cardiovasc Interv 1 2008 494 503
16. D.W. Park, S.W. Lee, and S.C. Yun et al. A point-of-care platelet function assay and C-reactive protein for prediction of major cardiovascular events after drug-eluting stent implantation J Am Coll Cardiol 58 2011 2630 2639
17. D.W. Park, Y.H. Kim, and H.G. Song et al. Outcomes after unrestricted use of everolimus-eluting and sirolimus-eluting stents in routine clinical practice: a multicenter, prospective cohort study Circ Cardiovasc Interv 5 2012 365 371
18. K. Thygesen, J.S. Alpert, and H.D. White et al. Universal definition of myocardial infarction Circulation 116 2007 2634 2653
19. W.K. Laskey, C.W. Yancy, and W.H. Maisel Thrombosis in coronary drug-eluting stents: report from the meeting of the Circulatory System Medical Devices Advisory Panel of the Food and Drug Administration Center for Devices and Radiologic Health, December 7-8, 2006 Circulation 115 2007 2352 2357
20. S.D. Wiviott, E.M. Antman, and C.M. Gibson et al. Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38) Am Heart J 152 2006 627 635
21. T.M. Therneau, and P.M. Grambsch Modeling survival data: extending the Cox model 2000 Springer New York
22. W.A. Ghali, H. Quan, and R. Brant et al. Comparison of 2 methods for calculating adjusted survival curves from proportional hazards models JAMA 286 2001 1494 1497
23. D.W. Park, Y.H. Kim, and S.C. Yun et al. Frequency, causes, predictors, and clinical significance of peri-procedural myocardial infarction following percutaneous coronary intervention Eur Heart J 34 2013 1662 1669
24. A.K. Jacobs, J.M. Johnston, and A. Haviland et al. Improved outcomes for women undergoing contemporary percutaneous coronary intervention: a report from the National Heart, Lung, and Blood Institute Dynamic registry J Am Coll Cardiol 39 2002 1608 1614
25. A.J. Lansky, J.S. Hochman, and P.A. Ward et al. Percutaneous coronary intervention and adjunctive pharmacotherapy in women: a statement for healthcare professionals from the American Heart Association Circulation 111 2005 940 953
26. S. Yang, Y.H. Khang, and H. Chun et al. The changing gender differences in life expectancy in Korea 1970-2005 Soc Sci Med 75 2012 1280 1287
27. K.W. Jung, S. Park, and A. Shin et al. Do female cancer patients display better survival rates compared with males? Analysis of the Korean National Registry data, 2005-2009 PloS one 7 2012 e52457
28. Abramson JL, Veledar E, Weintraub WS, et al. Association between gender and in-hospital mortality after percutaneous coronary intervention according to age. Am J Cardiol 2003;91:968-71, A4.
29. M. Singh, C.S. Rihal, and B.J. Gersh et al. Mortality differences between men and women after percutaneous coronary interventions. A 25-year, single-center experience J Am Coll Cardiol 51 2008 2313 2320
30. M.A Russ, C. Wackerl, and M. Hochadel et al. Do women receive inferior treatment for coronary artery disease? Gender based differences in the German ALKK-PCI registry Eur Heart J 33 Abstract Supplement 2012 9